OLLIER; Romain

Patent Applications and Registrations

Patent applications and USPTO patent grants for OLLIER; Romain.The latest application filed is for "t cell retargeting hetero-dimeric immunoglobulins".

Company Profile

3.2.15

OLLIER; Romain - La Chaux-de-Fonds CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
T Cell Retargeting Hetero-dimeric Immunoglobulins App 20220213227 - OLLIER; Romain	2022-07-07
Production Of T Cell Retargeting Hetero-dimeric Immunoglobulins App 20210171661 - BLEIN; Stanislas ; et al.	2021-06-10
Antibodies that bind to CCR6 and their uses Grant 10,640,564 - Lissilaa , et al.	2020-05-05
T Cell Retargeting Hetero-dimeric Immunoglobulins App 20200102403 - OLLIER; Romain	2020-04-02
Purification Of Hetero-dimeric Immunoglobulins App 20200010568 - BLEIN; Stanislas ; et al.	2020-01-09
Cd3/cd38 T Cell Retargeting Hetero-dimeric Immunoglobulins And Methods Of Their Production App 20190135918 - OLLIER; Romain ; et al.	2019-05-09
Production Of T Cell Retargeting Hetero-dimeric Immunoglobulins App 20180355064 - BLEIN; Stanislas ; et al.	2018-12-13
T Cell Retargeting Hetero-dimeric Immunoglobulins App 20180112011 - OLLIER; Romain	2018-04-26
Antibodies That Bind To Ccr6 And Their Uses App 20180086836 - LISSILAA; Rami ; et al.	2018-03-29
Anti-trka Antibodies With Enhanced Inhibitory Properties And Derivatives Thereof App 20170218087 - BLEIN; Stanislas ; et al.	2017-08-03
Production of T cell retargeting hetero-dimeric immunoglobulins App 20170145115 - BLEIN; Stanislas ; et al.	2017-05-25
Production of T cell retargeting hetero-dimeric immunoglobulins Grant 9,493,563 - Blein , et al. November 15, 2	2016-11-15
Anti-trka Antibodies With Enhanced Inhibitory Properties And Derivatives Thereof App 20160319027 - BLEIN; Stanislas ; et al.	2016-11-03
Purification Of Hetero-dimeric Immunoglobulins App 20150239991 - Blein; Stanislas ; et al.	2015-08-27
Anti-trka Antibodies With Enhanced Inhibitory Properties And Derivatives Thereof App 20150183885 - BLEIN; Stanislas ; et al.	2015-07-02
Production of T cell retargeting hetero-dimeric immunoglobulins App 20150133640 - BLEIN; Stanislas ; et al.	2015-05-14
Anti-trka Antibodies With Enhanced Inhibitory Properties And Derivatives Thereof App 20130344064 - BLEIN; STANISLAS ; et al.	2013-12-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.